1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with lutetium in 2 studies
Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (lutetium) | Trials (lutetium) | Recent Studies (post-2010) (lutetium) |
---|---|---|---|---|---|
195 | 3 | 161 | 1,192 | 44 | 844 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, JK; Jeong, JM; Jeong, SY; Ju, CH; Kim, YJ; Lee, BC; Lee, DS; Lee, MC; Lee, YS | 1 |
Dash, A; Gamre, N; Lohar, SP; Pandey, U | 1 |
2 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and lutetium
Article | Year |
---|---|
Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesis.
Topics: Animal Structures; Animals; Chelating Agents; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Delivery Systems; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Kidney; Lutetium; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Neovascularization, Pathologic; Oligopeptides; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2010 |
A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
Topics: Chelating Agents; Drug Stability; Durapatite; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; In Vitro Techniques; Lutetium; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Trace Elements | 2017 |